Positive FDA AdCom votes for Ardelyx's tenapanor
Ardelyx and Kyowa Hakko Kirin Announce License Agreement for Tenapanor for Cardiorenal Diseases in Japan
ARDX / Ardelyx, Inc. - Put/Call Ratio, Options Sentiment, Unusual Options Activity
Ardelyx wins FDA approval for phosphate absorption inhibitor - Pharmaceutical Technology
SEC Filing | Ardelyx, Inc.
Scripts : r/ARDELYX
Ardelyx, Inc. (ARDX) Stock Price, Quote & News - Stock Analysis
Hyperphosphatemia Pipeline Insight Report 2023 (Updated)
ARDX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 28, 2021 in the Class Action Filed on Behalf of Ardelyx, Inc. Limited Shareholders
Ardelyx, Inc. (ARDX) Stock Price, Quote & News - Stock Analysis
Ardelyx
Ardelyx Inc.(NASDAQ: ARDX)-Can it Continue to Outdo Estimates?
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities | Ardelyx, Inc.
SEC Filing | Ardelyx, Inc.
Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases | FinancialContent Business Page
🦍💎 $ARDX ✋🚀
Ardelyx Grants Stock Options & RSUs to New Employees
Ardelyx Prepares for Battle with FDA Over Rejected CKD Drug | BioSpace
FY2023 Earnings Forecast for Ardelyx, Inc. (NASDAQ:ARDX) Issued By Cantor Fitzgerald - MarketBeat
Ardelyx to Raise $110 Million in a Private Placement
Ardelyx: Q3 Earnings Snapshot -October 31, 2023 at 07:30 am EDT | MarketScreener
Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock Review
Ardelyx (@ardelyx) / X
Ardelyx
Ardelyx, Inc. (NASDAQ:ARDX) Q3 2023 Earnings Call Transcript
